IP Verse

Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna - EP4226941

EP4226941

GLAXOSMITHKLINE
Application Number
EP23179901A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Sep 20, 2024
Grant Date
Oct 23, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3682884B1
EP3480209B1
EP3564378B1

Bibliography

The patent EP4226941B1 was granted to Glaxosmithkline on Oct 23, 2024 following the initial filing on Aug 31, 2011 under the application number EP23179901A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ARROWHOUSEJul 23, 2025ADMISSIBLE
BIONTECHJul 22, 2025ADMISSIBLE
SANOFIJul 22, 2025ADMISSIBLE
WEICKMANN & WEICKMANNJul 22, 2025ADMISSIBLE
MODERNAJul 15, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents